Philippon F, Plumb V J, Epstein A E, Kay G N
Department of Medicine, University of Alabama at Birmingham 35294, USA.
Circulation. 1995 Aug 1;92(3):430-5. doi: 10.1161/01.cir.92.3.430.
Although radiofrequency catheter ablation of atrial flutter is associated with a high rate of initial success, several clinical issues regarding this therapy remain to be defined. For example, the risks of recurrent atrial flutter and of developing atrial fibrillation after flutter ablation are unknown. In addition, it is not known whether elimination of atrial flutter will modify the natural history of atrial fibrillation in patients who experience both of these arrhythmias. The purpose of the present study was to determine the actuarial freedom from recurrent or new atrial arrhythmias in patients with atrial flutter undergoing catheter ablation.
The study population consisted of 59 consecutive patients (mean age, 61.9 +/- 12.6 years) with typical atrial flutter who underwent catheter ablation of the reentrant circuit. Catheter ablation was not advised for patients in whom paroxysmal atrial fibrillation had been a major clinical problem. The inducibility of atrial fibrillation and atrial flutter was assessed after successful atrial flutter ablation with programmed atrial stimulation and rapid atrial pacing to a cycle length of 180 ms or 2:1 atrial capture. Atrial flutter was successfully ablated and rendered noninducible in 53 of 59 patients (90%). Over a mean follow-up period of 13.2 +/- 6.6 months, atrial flutter recurred in 5 patients (9.4%). Atrial fibrillation occurred in 14 of 53 patients after successful ablation (26.4%). Four clinical variables were associated by univariate analysis with the late occurrence of atrial fibrillation: (1) the presence of structural heart disease, (2) a history of atrial fibrillation before ablation of atrial flutter, (3) inducible sustained atrial fibrillation after ablation, and (4) a greater number of failed antiarrhythmic drugs. By multivariate analysis, only the persistent inducibility of sustained atrial fibrillation predicted the later development of atrial fibrillation.
Although atrial flutter ablation is highly effective and associated with a low risk of recurrent atrial flutter, atrial fibrillation continues to be a long-term risk for individuals undergoing this procedure. The risk of later atrial fibrillation is especially high for patients in whom sustained atrial fibrillation remains inducible after ablation of atrial flutter.
尽管心房扑动的射频导管消融术初始成功率较高,但关于该治疗方法仍有一些临床问题有待明确。例如,心房扑动复发以及扑动消融后发生心房颤动的风险尚不清楚。此外,对于同时患有这两种心律失常的患者,消除心房扑动是否会改变心房颤动的自然病程也不明确。本研究的目的是确定接受导管消融的心房扑动患者无复发性或新发房性心律失常的精算自由度。
研究人群包括59例连续的典型心房扑动患者(平均年龄61.9±12.6岁),他们接受了折返环的导管消融。阵发性心房颤动为主要临床问题的患者不建议进行导管消融。在成功消融心房扑动后,通过程控心房刺激和将心房起搏频率快速调整至180 ms或2:1心房夺获来评估心房颤动和心房扑动的诱发情况。59例患者中有53例(90%)成功消融心房扑动且不再能被诱发。在平均随访13.2±6.6个月期间,5例患者(9.4%)心房扑动复发。53例成功消融的患者中有14例(26.4%)发生了心房颤动。单因素分析显示,有4个临床变量与心房颤动的晚期发生相关:(1)存在结构性心脏病;(2)心房扑动消融前有心房颤动病史;(3)消融后可诱发持续性心房颤动;(4)抗心律失常药物治疗失败次数较多。多因素分析显示,只有持续性心房颤动的持续可诱发性可预测心房颤动的后期发生。
尽管心房扑动消融术非常有效且心房扑动复发风险较低,但心房颤动仍是接受该手术患者的长期风险。对于心房扑动消融后持续性心房颤动仍可诱发的患者,后期发生心房颤动的风险尤其高。